Cytembena administered in combination with cyclophosphamide in Yoshida ascitic sarcoma.
D000179:Acrylates / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology*; D001565:Benzoates / Q000494:pharmacology; D001772:Blood Cell Count; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D001966:Bromine / Q000494:pharmacology; D003520:Cyclophosphamide / Q000009:adverse effects / Q000494:pharmacology*; D051381:Rats; D012517:Sarcoma, Yoshida / Q000188:drug therapy*
D000179:Acrylates; D000970:Antineoplastic Agents; D001565:Benzoates; D003520:Cyclophosphamide; D001966:Bromine